| abstract |
The present invention's generality relates to the inflammatory diseases field of peripheral nervous system.More specifically, it relates to the method by regulating sphingosine-1-phosphate receptor activity to treat peripheral nervous system inflammatory diseases.In one embodiment, the invention provides the method that the object of chronic inflammatory demyelinative polyneuropathy (CIDP) or other autoimmune neurological disorders is suffered from treatment, it comprises the FTY720 to described subject effective amounts. |